Neratinib-d6 是 Neratinib 的氘代物。Neratinib (HKI-272) 是一种具有口服活性的，不可逆的 tyrosine kinase 抑制剂，能够抑制 HER2 和 EGFR 的活性，IC50 值分别为 59 nM 和 92 nM。
| 生物活性 |
Neratinib-d6 (HKI-272-d6) is the deuterium labeled Neratinib. Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor with IC50s of 59 nM and 92 nM for HER2 and EGFR, respectively. |
|---|---|
| 体外研究 |
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs. |
| 分子量 |
563.08
|
| CAS号 |
1259519-18-0
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
纯度： 98%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet